These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14789419)

  • 1. Agranulocytosis in conjunction with neoarsphenamine treatment.
    HARD S
    Acta Derm Venereol; 1950; 30(5):449-50. PubMed ID: 14789419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical aspects and pathogenesis of agranulocytosis caused by neosalvarsan, with notes on experiments with animals].
    KRUGER H
    Dermatol Wochenschr; 1950; 122(41):975-86; contd. PubMed ID: 14812900
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical aspects and pathogenesis of agranulocytosis caused by neosalvarsan, with notes on experiments with animals. II].
    KRUGER H
    Dermatol Wochenschr; 1950; 122(42):999-1009. PubMed ID: 14812901
    [No Abstract]   [Full Text] [Related]  

  • 4. [About Salvarsanagranulocytosis].
    KUHL J
    Med Klin; 1947 Mar; 42(6):233-5. PubMed ID: 20296558
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salvarsan allergy (ninth-day erythema and agranulocytosis)].
    WEISENBERG G
    Dermatol Wochenschr; 1950; 122(30):711-5. PubMed ID: 15435120
    [No Abstract]   [Full Text] [Related]  

  • 6. Agranulocytosis following administration of acetylarsan injections.
    MATHUR TN
    J Indian Med Assoc; 1952 Sep; 21(12):521-3. PubMed ID: 13000165
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early recognition and prevention of salvarsan agranulocytosis].
    LOISCH ZN
    Munch Med Wochenschr; 1955 Aug; 97(33):1048-51. PubMed ID: 13265669
    [No Abstract]   [Full Text] [Related]  

  • 8. Observations on the physico-chemical properties of arsphenamine and neoarsphenamine.
    MUIC N; FLES D
    Acta Med Iugosl; 1951; 5(3):265-81. PubMed ID: 14877493
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvarsan agranulocytosis cured.
    BAUMGARTEN I
    Acta Derm Venereol; 1946 Jan; 26():301-3. PubMed ID: 21066700
    [No Abstract]   [Full Text] [Related]  

  • 10. [Syndrome of agranulocytosis following arsenobenzol therapy; therapeutic trial of vitamin B12].
    LIMBOS P; COURTOIS G
    Ann Soc Belg Med Trop (1920); 1951 Feb; 31(1):121-7. PubMed ID: 14838453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of neoarsphenamine].
    Medika (Zagreb); 1950 Oct; 3(10):146. PubMed ID: 14785509
    [No Abstract]   [Full Text] [Related]  

  • 12. Aplastic anaemia following neoarsphenamine.
    HART FD; HUMBLE JG
    Br Med J; 1949 Jun; 1(4616):1120. PubMed ID: 18153425
    [No Abstract]   [Full Text] [Related]  

  • 13. Assay of the curative action of neoarsphenamine by time-mortality data.
    LILJESTRAND A
    J Pharm Pharmacol; 1949 Feb; 1(2):78-86. PubMed ID: 18111470
    [No Abstract]   [Full Text] [Related]  

  • 14. WHAT'S your diagnosis? (Hemorrhagic encephalitis due to neoarsphenamine).
    Am Pract Dig Treat; 1950 Nov; 1(11):1176-7. PubMed ID: 14771431
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the influences of mapharsen on fixed neoarsphenamine eruptions; preliminary report.
    ABE M
    Tohoku J Exp Med; 1950 May; 52(1-2):48. PubMed ID: 14776730
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoarsphenamine in acute eperythrozoonosis of swine.
    SPLITTER EJ
    J Am Vet Med Assoc; 1950 Nov; 117(884):371-3. PubMed ID: 14784431
    [No Abstract]   [Full Text] [Related]  

  • 17. The determination of the toxicity of neoarsphenamine in rats by a method based on survival-time.
    ALLMARK MG; LAVALLEE A
    J Am Pharm Assoc Am Pharm Assoc; 1950 Feb; 39(2):81-4. PubMed ID: 15405479
    [No Abstract]   [Full Text] [Related]  

  • 18. A sterility test for neoarsphenamine B.P. and sulpharsphenamine B.P. for injection.
    SYKES G; ROYCE A; HUGO WB
    J Pharm Pharmacol; 1952 Jun; 4(6):366-72. PubMed ID: 14946682
    [No Abstract]   [Full Text] [Related]  

  • 19. A case report of fulminant occlusive arterial disease with gangrene of the extremities, due to neoarsphenamine intoxication.
    LINDSTROM LJ
    Acta Chir Scand; 1950; 100(5):509-14. PubMed ID: 14818601
    [No Abstract]   [Full Text] [Related]  

  • 20. Tests on the resistance of the B. coli and the staphylococci in the urine to neoarsphenamine and sulfathiazole.
    TUOVINEN PI
    Ann Med Exp Biol Fenn; 1949; 27(2):128-33. PubMed ID: 15392079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.